FRANKFURT, Jan 3 (Reuters) – Investors are demanding around 2.2 billion euros ($2.5 billion) from Bayer (BAYGn.DE) as part of a possible class action lawsuit in Germany over the takeover of U.S. seed manufacturer Monsanto, law firm Tilp said on Monday.
The law firm said that as of Dec. 30, the sum covered lawsuits from about 320 investors, both institutional and retail, that had been filed with the district court in Cologne.
This represents a significant jump from the 250-plus investors demanding damages of more than 1 billion euros that Tilp disclosed last month. read more
Tilp has said it believes Bayer deceived shareholders about the risks of consumer lawsuits pending in the United States linked to the weed killer Roundup, which was brought into the company with the $63 billion acquisition of Monsanto in 2016.
Bayer, in an emailed statement, said any complaints were unfounded, adding the company had complied with the law and disclosure requirements.
“In addition we are convinced that we have carried out adequate due diligence regarding the acquisition of Monsanto,” Bayer said, adding it would defend itself accordingly.
In the United States, Bayer is defending itself against thousands of lawsuits by Roundup users because of the alleged carcinogenic effect of the product. Bayer has always rejected this.
($1 = 0.8857 euros)
Convenience retail is becoming an increasingly data-driven business, with operators balancing tight margins, shifting consumer…
As enterprises have moved more workloads into virtualised environments, the hypervisor has become a critical…
Rally Saudi Arabia will not form part of the 2026 FIA World Rally Championship due…
Outdoor footwear is increasingly expected to do more than perform on a trail. Consumers move…
The non-alcoholic beverage market is beginning to move beyond the simple promise of drinking less.…
For clean-energy technology companies, sustainability reporting is increasingly moving beyond a compliance exercise. Investors, customers…